Literature DB >> 29501364

Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

Pierre Blanchard1, Yungan Tao2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29501364     DOI： 10.1016/S1470-2045(18)30113-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  3 in total

1.  Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.

Authors:  Zhiru Li; Chao Li; Dong Yang; Junmei Song; Ting Liu; Ziyan Zhou; Lifang Zhou; Min Kang
Journal:  BMC Cancer       Date:  2022-06-06       Impact factor: 4.638

2.  Encapsulation of Nedaplatin in Novel PEGylated Liposomes Increases Its Cytotoxicity and Genotoxicity against A549 and U2OS Human Cancer Cells.

Authors:  Salma El-Shafie; Sherif Ashraf Fahmy; Laila Ziko; Nada Elzahed; Tamer Shoeib; Andreas Kakarougkas
Journal:  Pharmaceutics       Date:  2020-09-10       Impact factor: 6.321

3.  Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells.

Authors:  Lianggui Jiang; Wen-Chu Ye; Zuobiao Li; Yongguang Yang; Wei Dai; Mingyi Li
Journal:  BMC Complement Med Ther       Date:  2021-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.